Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
Garcia
David
D
University of New Mexico, Albuquerque, 87131, USA. davgarcia@salud.unm.edu
Ageno
Walter
W
Bussey
Henry
H
Eikelboom
John
J
Margaglione
Maurizio
M
Marongiu
Francesco
F
Moia
Marco
M
Palareti
Gualtiero
G
Pengo
Vittorio
V
Poli
Daniela
D
Schulman
Sam
S
Witt
Dan
D
Wittkowksy
Ann
A
Crowther
Mark
M
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D019468:Disease Management; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D019934:International Normalized Ratio; D010597:Pharmacogenetics; D013927:Thrombosis / Q000150:complications / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D014812:Vitamin K